SCHEMBL4967153

SCHEMBL4967153

CC(=O)CCc1ccc(Br)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.47
ALDH1A1 P00352 5/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
GSK3B P49841 2/20 0.40
DAO P14920 1/20 0.39
LMNA P02545 3/20 0.39
RXFP1 Q9HBX9 2/20 0.39
PRNP P04156 1/20 0.39
RECQL P46063 1/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KMT2A Q03164 1/20 0.38
IAPP P10997 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3515628 0.82 RPS6KB2 (0.45) L3MBTL1ALDH1A1CES2CES1GSK3B
SCHEMBL5320621 0.80 RPS6KB2 (0.51) L3MBTL1ALDH1A1LMNAKDM4EHPGD
SCHEMBL2615871 0.80 L3MBTL1 (0.50) L3MBTL1ALDH1A1CES2CES1GSK3B
SCHEMBL10639931 0.77 ALDH1A1 (0.63) L3MBTL1ALDH1A1GSK3BLMNARXFP1
SCHEMBL27748238 0.77 L3MBTL1 (0.44) L3MBTL1ALDH1A1CES2CES1GSK3B
SCHEMBL1414863 0.76 KDM4E (0.45) L3MBTL1ALDH1A1CES2CES1GSK3B
SCHEMBL9685034 0.76 ALDH1A1 (0.53) L3MBTL1ALDH1A1DAOLMNARXFP1
SCHEMBL14741248 0.74 ALDH1A1 (0.40) L3MBTL1ALDH1A1LMNARXFP1PRNP
SCHEMBL7474007 0.74 HPGD (0.58) L3MBTL1ALDH1A1LMNARXFP1PRNP
SCHEMBL482444 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2750505-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033240-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed
EP-1966194-A2 SUBSTITUTED 5-HETEROARYL-1-PHENYL-PYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-09-10 EP disclosed
WO-2007061948-A2 SUBSTITUTED 5-HETEROARYL-1-PHENYL-PYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-05-31 WO disclosed